Measuring Pharma Insights and Research ROI
Pharmaceutical companies spend millions on market research, competitive intelligence, real-world evidence (RWE), artificial intelligence (AI), forecasting and statistical analysis to help inform strategic decisions. But gathering insights is only part of the equation. Thus, business leaders are increasingly looking to research teams to show how their work is contributing to measurable business outcomes.
To measure ROI on pharma insights, you need to look beyond the number of studies completed or reports delivered. The real value is in how research influences product development, launch planning, commercial strategy, market access and long-term business health. Organisations that measure research ROI effectively are better able to prioritise investments, improve decision-making and elevate the strategic role of insights across the business.
Explore who should attend the Executive Pharma Insights Conference
Why Research ROI Measurement Matters
Research is time-consuming, technological, and expertise-demanding.
What is the advantage of measuring ROI for organisations?
-
Show business value
-
Resource allocation optimisation
-
Assistance with strategic planning
-
Build confidence in executives.
-
Focus on high-impact research.
-
Drive continuous improvement
Insights teams are strategic partners, not service providers, when research results are linked to business objectives.
Match Research to Business Needs
Every research project has to commence with a clear business objective.
Research often supports:
-
Products Development
-
New Product Launches
-
Access to markets
-
Portfolio planning
-
Business Strategy
-
Positionamento competitivo
Clear objectives make it easier to determine if the research delivered business value.
Measure Strategic Decision-Making
Impact on critical business decisions is one of the best signs of research value.
Organisations need to determine if research shows:
-
Product placement
-
Pricing strategy
-
Prediction
-
Investment choices
-
Clinical development
-
Business planning
Research that informs strategic decisions is of real value to organisations.
Explore strategic planning opportunities across the pharmaceutical industry
Watch the Commercial Performance
Another way to judge research effectiveness is business performance.
Useful metrics are:
-
Successful launch
-
Growth in market share
-
Forecast precision
-
Sales growth
-
Engagement with consumers
-
Growth of portfolio
Many things affect these outcomes, but organisations can usually tell where research made a difference to better performance.
Assess Cross-Functional Impact
The more departments use the findings, the more value research generates.
Successful organisations foster collaboration across:
-
Market studies
-
Medical Affairs
-
Business strategy
-
Access to market
-
Regulatory affairs
-
Executive management
Research that enhances cross-functional decision-making often has a greater impact on organisations.
Measure Efficiency of Operations
Research teams should monitor operational performance as well.
Useful indicators are:
-
Project completion time
-
Quality of research
-
Accuracy of data
-
Efficiency of reporting
-
Knowledge transfer
-
Engagement with key stakeholders
Operational efficiency can be enhanced to increase responsiveness of organisations to changing market conditions.
Include Patient and Customer Results
Research success shouldn’t be limited to internal business metrics.
Organisations are increasingly measuring:
-
Patient engagement
-
Adherence to therapy
-
Health care professional satisfaction
-
User experience
-
Support program effectiveness
-
Actual results
Commercial and patient-centric measures combined provide a broader view of the value of research.
Use Artificial Intelligence To Monitor Performance
Artificial intelligence is changing how organisations measure research effectiveness.
AI supports:
-
Dashboards for performance
-
Predictive Analytics
-
Trend analysis
-
Automatic Report
-
Executive insights
-
Business Intelligence
These technologies enable research teams to analyse larger datasets and spend more time on strategic interpretation.
Creating a Culture of Continuous Improvement
Organisations that maximise their benefits from research regularly assess their performance.
Best practices are:
-
KPI-Review
-
Measurement of business results
-
Improving research methods
-
Telling success stories
-
Investment in developing the team
-
Collaboration enhancement
Ongoing assessment ensures research efforts remain in step with evolving business priorities.
Executive Conference on Pharma Insights (EPIC)
The Executive Pharma Insights Conference (EPIC) brings together pharma executives, market researchers, commercial leaders, medical affairs professionals, market access specialists, data scientists, healthcare experts and technology innovators focused on improving strategic decision-making. The EPIC Conference will provide you with practical ways to measure business impact using market research, artificial intelligence, competitive intelligence, forecasting, real-world evidence, and advanced analytics. EPIC Market Research & Insights offers a collaborative platform for professionals in the pharmaceutical industry to share best practices, gain insights from real-world case studies, and develop actionable frameworks for demonstrating the value of insights across the pharmaceutical enterprise. The Pharma Insights Conference is a great networking opportunity for companies looking to improve performance measurement, increase collaboration and develop more effective insights functions.
Explore the role of market research in pharma strategy.
As pharma companies continue to embrace artificial intelligence, predictive analytics, real-world evidence and integrated data ecosystems, it will be even more critical to measure the strategic impact of insights teams. Organisations will start judging success by how insights translate into better business decisions and organisational performance, not by the volume of research produced.
Firms with sound performance indicators, enhanced cross-functional collaboration and continued assessment of business impact will be better poised to accelerate innovation, enhance commercialisation, optimise market access and provide enhanced value to healthcare professionals and patients.